Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) Annual Conference
16th International Congress on Infectious Diseases
SHEA Spring Conference 2014
Correctional Health Care Conference to Address Patient Care Amidst Growing Health Care Costs
Find Practice Guidelines
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
IDSA Applauds President’s Commitment to Combatting Antibiotic Resistance in FY 2015 Budget, Dismayed by Related Reductions
President Obama’s Fiscal Year 2015 budget includes a request to more than double funding for the CDC to combat antibiotic resistance, in addition to requests to fund efforts to track, prevent and control antibiotic resistance in the U.S. and around the world.
IDSA Applauds State of the Union Pledge on Drug Resistance
The Society reiterated its support for the Antibiotic Development to Advance Patient Treatment Act and the Strategies to Address Antimicrobial Resistance Act.
ADAPT Act Introduced to Establish New Drug Approval Pathway
IDSA applauds the bipartisan introduction of legislation to establish a new limited-population antibacterial and antifungal drug approval pathway.
IDSA Seeks Obama Admin Support for AMR Legislation
A letter sent to President Obama asks for support for current bills addressing antimicrobial resistance. Proposals include the LPAD Pathway, tax credits for research and development of drugs and diagnostics, STAAR Act, and federal funding.
Capitol Hill Briefing on Antibiotic Resistance Threats to the U.S.
IDSA, CDC, and Pew Charitable Trusts will hold a briefing on the new report from CDC on antibiotic resistant threats to the US.
IDSA Releases Core Principles for Antibacterial Drug Pathway (PDF)
IDSA and other groups outline a proposed new law to create a limited population antibacterial drug (LPAD) pathway.
Broad U.S. Response Needed to Address Pertussis (PDF)
IDSA and the Pediatric Infectious Diseases Society provided recommendations to federal health agencies to help address the rising incidence of pertussis.
More than 20 Groups Applaud STAAR Act Reintroduction (PDF)
An IDSA-led coalition welcomed the reintroduction of legislation to help address antimicrobial resistance.
1 of 8
Human Infection with Avian Influenza A (H5N1) Virus
Notice to Clinicians: Early Reports of pH1N1-Associated Illnesses for the 2013-14 Influenza Season
Abrams Royal Pharmacy Issues Voluntary Nationwide Recall
Drug Information Update- FDA approves Sovaldi for chronic hepatitis C
>> Read More (Log-In Required)
In this issue:•President's Message: Volunteering with IDSA•Call for Nominations•Antimicrobial Resistance Efforts•IDWeek 2014 Registration•IDSA Journal Club
IDSA is seeking member nominations for two Board of Director positions and Vice President.
>> Read more
Modifying how urine culture results are reported can improve prescribing practices, a pilot study in Clinical Infectious Diseases suggests.
New IDSA-AASLD website offers timely guidance on treatment of hepatitis C virus infection, in collaboration with IAS-USA.
In this issue:President's Message: HCVguidelines.orgADAPT Act Updated GuidelineIDSA Journal Club
In this issue:
People with compromised immune systems often aren’t vaccinated, but most should be, says a new practice guideline from IDSA.
Antiretroviral therapy (ART) for HIV has saved millions of years of life in the country, with even greater gains possible, a new study in The Journal of Infectious Diseases finds.
1 of 7
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America